These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 2667601)

  • 1. Lack of effect of spiramycin on cyclosporin pharmacokinetics.
    Vernillet L; Bertault-Peres P; Berland Y; Barradas J; Durand A; Olmer M
    Br J Clin Pharmacol; 1989 Jun; 27(6):789-94. PubMed ID: 2667601
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lack of effect of isradipine on cyclosporin pharmacokinetics.
    Vernillet L; Bourbigot B; Codet JP; Le Saux L; Moal MC; Morin JF
    Fundam Clin Pharmacol; 1992; 6(8-9):367-74. PubMed ID: 1292968
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Slow accumulation of cyclosporin metabolites as measured by specific and nonspecific cyclosporin RIA.
    Keller F; Kunzendorf U; Walz G; Schwarz A; Offermann G
    Int J Clin Pharmacol Ther Toxicol; 1990 Apr; 28(4):167-75. PubMed ID: 2338370
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lack of effect of spiramycin on cyclosporin pharmacokinetics.
    Kessler M; Netter P; Renoul HE; Trechot P; Dousset B; Bannwarth B
    Br J Clin Pharmacol; 1990 Mar; 29(3):370-1. PubMed ID: 2360926
    [No Abstract]   [Full Text] [Related]  

  • 5. Spiramycin does not increase plasma cyclosporin concentrations in renal transplant patients.
    Kessler M; Netter P; Zerrouki M; Renoult E; Trechot P; Dousset B; Jonon B; Mur JM
    Eur J Clin Pharmacol; 1988; 35(3):331-2. PubMed ID: 3053210
    [No Abstract]   [Full Text] [Related]  

  • 6. The effects of spiramycin on plasma cyclosporin A concentrations in heart transplant patients.
    Guillemain R; Billaud E; Dreyfus G; Amrein C; Kitzis M; Jebara VA; Kreft-Jais C
    Eur J Clin Pharmacol; 1989; 36(1):97-8. PubMed ID: 2645146
    [No Abstract]   [Full Text] [Related]  

  • 7. Evaluation of cyclosporin-phenytoin interaction with observations on cyclosporin metabolites.
    Freeman DJ; Laupacis A; Keown PA; Stiller CR; Carruthers SG
    Br J Clin Pharmacol; 1984 Dec; 18(6):887-93. PubMed ID: 6529529
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of ponsinomycin on cyclosporin pharmacokinetics.
    Couet W; Istin B; Seniuta P; Morel D; Potaux L; Fourtillan JB
    Eur J Clin Pharmacol; 1990; 39(2):165-7. PubMed ID: 2253667
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monitoring cyclosporin concentrations in marrow transplant recipients: comparison of two assay methods.
    Yee GC; Kennedy MS; Gmur DJ; Self SG; Deeg HJ
    Bone Marrow Transplant; 1987 Feb; 1(3):289-95. PubMed ID: 3332139
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical pharmacokinetics of cyclosporin.
    Ptachcinski RJ; Venkataramanan R; Burckart GJ
    Clin Pharmacokinet; 1986; 11(2):107-32. PubMed ID: 3514043
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cyclosporin-erythromycin interaction in renal transplant patients.
    Gupta SK; Bakran A; Johnson RW; Rowland M
    Br J Clin Pharmacol; 1989 Apr; 27(4):475-81. PubMed ID: 2655690
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetic interaction between cyclosporin and diltiazem.
    Brockmöller J; Neumayer HH; Wagner K; Weber W; Heinemeyer G; Kewitz H; Roots I
    Eur J Clin Pharmacol; 1990; 38(3):237-42. PubMed ID: 2340843
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclosporin A blood levels during use of cyclosporin as oral solution or in capsules: comparison of pharmacokinetic parameters.
    Hilbrands LB; Hoitsma AJ; van den Berg JW; Koene RA
    Transpl Int; 1991 Jun; 4(2):125-7. PubMed ID: 1910430
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyclosporin-erythromycin interaction in normal subjects.
    Freeman DJ; Martell R; Carruthers SG; Heinrichs D; Keown PA; Stiller CR
    Br J Clin Pharmacol; 1987 Jun; 23(6):776-8. PubMed ID: 3606938
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of erythromycin, josamycin and spiramycin on rat polymorphonuclear leukocyte chemotaxis.
    Eyraud A; Descotes J; Lombard JY; Laschi-Loquerie A; Tachon P; Veysseyre C; Evreux JC
    Chemotherapy; 1986; 32(4):379-82. PubMed ID: 3731922
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyclosporine kinetics in renal transplant patients as assessed by high-performance liquid chromatography and radioimmunoassay using monoclonal and polyclonal antibodies.
    Speck RF; Frey FJ; Frey BM
    Transplantation; 1989 May; 47(5):802-6. PubMed ID: 2655217
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic drug monitoring of cyclosporin. Practical applications and limitations.
    Rodighiero V
    Clin Pharmacokinet; 1989 Jan; 16(1):27-37. PubMed ID: 2650953
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Lack of effect of a spiramycin/metronidazole combination on the pharmacokinetics of antipyrine].
    Descotes J; Simonet R; Evreux JC
    Rev Odontostomatol (Paris); 1986; 15(3):233-5. PubMed ID: 3462877
    [No Abstract]   [Full Text] [Related]  

  • 19. Cyclosporine (cyclosporin A) pharmacokinetics in renal transplant patients receiving ciprofloxacin.
    Lang J; Finaz de Villaine J; Garraffo R; Touraine JL
    Am J Med; 1989 Nov; 87(5A):82S-85S. PubMed ID: 2589391
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effect of diltiazem on blood cyclosporin levels].
    Kunzendorf U; Walz G; Neumayer HH; Wagner K; Keller F; Offermann G
    Klin Wochenschr; 1987 Nov; 65(22):1101-3. PubMed ID: 3320488
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.